Patent Opposition Database

Join our community to challenge unmerited drug patents

  1. Home
  2. Drugs
  3. Dolutegravir/Abacavir/Lamivudine
  4. Lek Pharmaceuticals Opposition, Dolutegravir/Abacavir/Lamivudine , (Ep2531027)

Lek Pharmaceuticals Opposition, Dolutegravir/Abacavir/Lamivudine , (Ep2531027)

Download Pdf Subscribe to updates

No Annotations

Related patent application (please put in national patent application/publication number or PCT application/publication number)
EP2531027
Who filed
LEK Pharmaceuticals
Country
Europe (EPO)
Opposition type
Post-Grant
Opposition status
Granted
Date
05-02-2016
Patent type
Combination
No Annotations

Add an annotation

Where in the document

Click within the document, or manually enter the page number below

Be as descriptive as necessary

Cancel

2 similar patent oppositions